544445 — Asston Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹755.98m
- IN₹794.10m
- IN₹250.39m
- 20
- 37
- 26
- 13
Annual cashflow statement for Asston Pharmaceuticals, fiscal year end - March 31st, millions except per share.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ||
| Standards: | — | — | IAS | IAS | IAS |
| Status: | fx Preliminary | fx Preliminary | Final | Final | Final |
| Net Income/Starting Line | — | — | 14.1 | 18.2 | 57 |
| Depreciation | |||||
| Non-Cash Items | — | — | 10.6 | 14.6 | 9.56 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | — | -28.2 | -71.2 | -69 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | — | -3.16 | -38 | -1.63 |
| Capital Expenditures | — | — | -2.51 | -0.103 | -1.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -6.61 | 0.049 | -7.58 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | — | -9.12 | -0.054 | -8.68 |
| Financing Cash Flow Items | — | — | -7.21 | -9.33 | 9.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | 12.1 | 36.9 | 5.13 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | — | -0.131 | -1.17 | -5.18 |